Dysregulation of Tissue Factor, Thrombin-Activatable Fibrinolysis Inhibitor, and Fibrinogen in Patients Undergoing Total Joint ArthroplastyChristopher Wanderling, Jawed Fareed, Jeffrey Liles et al.|Clinical and Applied Thrombosis/Hemostasis|2017Cited by 19
Increased Level of Thrombotic Biomarkers in Patients with Atrial Fibrillation Despite Traditional and New Anticoagulant TherapyJeffrey Liles, Jawed Fareed, Jordan Liles et al.|Clinical and Applied Thrombosis/Hemostasis|2016Cited by 19
Perioperative Factors and Their Effect on the Fibrinolytic System in Arthroplasty PatientsAndrew Burleson, William Hopkinson, Christopher Wanderling et al.|Clinical and Applied Thrombosis/Hemostasis|2015Cited by 13
Levels of Matrix-Degrading Enzymes and Lubricin in Patients With Degenerative Joint Disease Requiring ArthroplastyChristopher Wanderling, William Hopkinson, Jeffrey Liles et al.|Clinical and Applied Thrombosis/Hemostasis|2017Cited by 9
Synovial Fluid Analysis in Patients with Osteoarthritis Requiring Total Joint ArthroplastyElissa S. Davis, William Hopkinson, Christopher Wanderling et al.|World Journal of Surgery and Surgical Research|2018Cited by 2